OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study
B. Molina, Roberto Padoan, Maria Letizia Urban, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 12, pp. 1587-1593
Closed Access | Times Cited: 28
B. Molina, Roberto Padoan, Maria Letizia Urban, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 12, pp. 1587-1593
Closed Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence
Marco Caminati, Claudio Micheletto, Francesca Norelli, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 1-2, pp. 15-23
Closed Access | Times Cited: 7
Marco Caminati, Claudio Micheletto, Francesca Norelli, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 1-2, pp. 15-23
Closed Access | Times Cited: 7
Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma
Nina Vincent-Galtié, Quentin Marquant, Émilie Catherinot, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Nina Vincent-Galtié, Quentin Marquant, Émilie Catherinot, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Update on targeted treatments for ANCA-associated vasculitis
Xavier Puéchal
Joint Bone Spine (2025) Vol. 92, Iss. 1, pp. 105768-105768
Open Access
Xavier Puéchal
Joint Bone Spine (2025) Vol. 92, Iss. 1, pp. 105768-105768
Open Access
Heterogeneity and individualized therapy for eosinophilic granulomatosis with polyangiitis
Lijuan Hua, Min Xie
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access
Lijuan Hua, Min Xie
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access
Highlights from the plenary session: eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome
Julia U. Holle, Augusto Vaglio
Lara D. Veeken (2025) Vol. 64, Iss. Supplement_1, pp. i92-i97
Closed Access
Julia U. Holle, Augusto Vaglio
Lara D. Veeken (2025) Vol. 64, Iss. Supplement_1, pp. i92-i97
Closed Access
Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden
Julia U. Holle, Torsten Kubacki, Philippe Ariès, et al.
Zeitschrift für Rheumatologie (2025) Vol. 84, Iss. 3, pp. 225-251
Closed Access
Julia U. Holle, Torsten Kubacki, Philippe Ariès, et al.
Zeitschrift für Rheumatologie (2025) Vol. 84, Iss. 3, pp. 225-251
Closed Access
Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden
Julia U. Holle, Torsten Kubacki, Philippe Ariès, et al.
Zeitschrift für Rheumatologie (2025) Vol. 84, Iss. S1, pp. 1-49
Closed Access
Julia U. Holle, Torsten Kubacki, Philippe Ariès, et al.
Zeitschrift für Rheumatologie (2025) Vol. 84, Iss. S1, pp. 1-49
Closed Access
Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities
Paneez Khoury, Florence Roufosse, Fei Li Kuang, et al.
Journal of Leukocyte Biology (2024)
Open Access | Times Cited: 3
Paneez Khoury, Florence Roufosse, Fei Li Kuang, et al.
Journal of Leukocyte Biology (2024)
Open Access | Times Cited: 3
Dupilumab's impact on nasal citology: Real life experience after 1 year of treatment
Matteo Gelardi, Rossana Giancaspro, Vitaliano Nicola Quaranta, et al.
American Journal of Otolaryngology (2024) Vol. 45, Iss. 4, pp. 104275-104275
Open Access | Times Cited: 3
Matteo Gelardi, Rossana Giancaspro, Vitaliano Nicola Quaranta, et al.
American Journal of Otolaryngology (2024) Vol. 45, Iss. 4, pp. 104275-104275
Open Access | Times Cited: 3
A REAL-WORLD STUDY OF SYMPTOMATIC EOSINOPHILIA IN MODERATE TO SEVERE ASTHMA PATIENTS ON DUPILUMAB THERAPY
Matthew Fisch, Merritt L. Fajt, Sally E. Wenzel, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 8, pp. 2183-2186
Closed Access | Times Cited: 3
Matthew Fisch, Merritt L. Fajt, Sally E. Wenzel, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 8, pp. 2183-2186
Closed Access | Times Cited: 3
Successful combination therapy of mepolizumab and dupilumab in a patient with EGPA: a future therapeutic option?
Joana Martins-Martinho, Roberto Pereira da Costa, Tiago Abreu, et al.
Rheumatology Advances in Practice (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 2
Joana Martins-Martinho, Roberto Pereira da Costa, Tiago Abreu, et al.
Rheumatology Advances in Practice (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 2
The use of dupilumab in treatment-refractory eosinophilic fasciitis
Chen Wang, Elle Flood, Amy D. Klion, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 2, pp. 213-215
Closed Access | Times Cited: 2
Chen Wang, Elle Flood, Amy D. Klion, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 2, pp. 213-215
Closed Access | Times Cited: 2
Treatment strategies for ANCA-associated vasculitides: from standard protocols to future horizons
Francesco Reggiani, Matteo Stella, Marta Calatroni, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 7, pp. 765-780
Closed Access | Times Cited: 1
Francesco Reggiani, Matteo Stella, Marta Calatroni, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 7, pp. 765-780
Closed Access | Times Cited: 1
Asthma loss of control after switch from anti-IL-5/5R drugs to dupilumab in severe eosinophilic asthma: A case series
Camille Poisson, Cécile Chenivesse, E. Cuvillon, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 7, pp. 1914-1917
Closed Access | Times Cited: 1
Camille Poisson, Cécile Chenivesse, E. Cuvillon, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 7, pp. 1914-1917
Closed Access | Times Cited: 1
Dupilumab use in patients with hypereosinophilic syndromes: a multicenter case series and review of the literature
Ejiofor A.D. Ezekwe, Andrew L. Weskamp, Rodaba Rahim, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024)
Closed Access | Times Cited: 1
Ejiofor A.D. Ezekwe, Andrew L. Weskamp, Rodaba Rahim, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024)
Closed Access | Times Cited: 1
Dupilumab-induced rhinitis in severe asthma patients: A case series
Goël Fenech, Muriel Hourseau, J. Cristofari, et al.
Respiratory Medicine and Research (2023) Vol. 85, pp. 101072-101072
Closed Access | Times Cited: 2
Goël Fenech, Muriel Hourseau, J. Cristofari, et al.
Respiratory Medicine and Research (2023) Vol. 85, pp. 101072-101072
Closed Access | Times Cited: 2
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics
Mario Andrea Piga, Paolo Fraticelli, Leonardo Antonicelli, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Mario Andrea Piga, Paolo Fraticelli, Leonardo Antonicelli, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Management of ANCA-associated vasculitides
Christian Löffler, Bernhard Hellmich
Deleted Journal (2024) Vol. 65, Iss. 2, pp. 93-106
Closed Access
Christian Löffler, Bernhard Hellmich
Deleted Journal (2024) Vol. 65, Iss. 2, pp. 93-106
Closed Access
Biologics in Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis
Ejiofor A.D. Ezekwe, Andrew L. Weskamp, Luke Pittman, et al.
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 4, pp. 629-644
Closed Access
Ejiofor A.D. Ezekwe, Andrew L. Weskamp, Luke Pittman, et al.
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 4, pp. 629-644
Closed Access
Therapie-Update der ANCA-assoziierten Vaskulitiden
Julia U. Holle, Frank Moosig
Zeitschrift für Rheumatologie (2024) Vol. 83, Iss. 10, pp. 787-799
Closed Access
Julia U. Holle, Frank Moosig
Zeitschrift für Rheumatologie (2024) Vol. 83, Iss. 10, pp. 787-799
Closed Access
Dupilumab-related eosinophilia in patients with severe asthma: Post-marketing surveillance in Japan
Makoto Nagata, Ryo Yamaguchi, Makiko Usami, et al.
Allergology International (2024)
Open Access
Makoto Nagata, Ryo Yamaguchi, Makiko Usami, et al.
Allergology International (2024)
Open Access
Solo Addition of Mepolizumab Turned Antineutrophil Cytoplasmic Antibody Negative and Achieved Glucocorticoid Discontinuation in a Patient with Eosinophilic Granulomatosis with Polyangiitis: A Case Report
Takashi Yamane, Akira Hashiramoto
Internal Medicine (2024)
Open Access
Takashi Yamane, Akira Hashiramoto
Internal Medicine (2024)
Open Access
Dupilumab for refractory chronic rhinosinusitis in eosinophilic granulomatosis with polyangiitis
Roberto Padoan, F. Davanzo, Luca Iorio, et al.
Lara D. Veeken (2024)
Closed Access
Roberto Padoan, F. Davanzo, Luca Iorio, et al.
Lara D. Veeken (2024)
Closed Access
Characteristics of Severe Asthma Clinic Patients with Eosinophilic Granulomatosis with Polyangiitis
You Xin Puan, Kheng Yong Ong, Pei Yee Tiew, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024)
Open Access
You Xin Puan, Kheng Yong Ong, Pei Yee Tiew, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024)
Open Access
Ten clinical conundrums in the management of eosinophilic granulomatosis with polyangiitis
Íñigo Rúa‐Figueroa, Roser Soláns-Laqué, Marina Blanco–Aparicio, et al.
Expert Review of Clinical Immunology (2024), pp. 1-15
Closed Access
Íñigo Rúa‐Figueroa, Roser Soláns-Laqué, Marina Blanco–Aparicio, et al.
Expert Review of Clinical Immunology (2024), pp. 1-15
Closed Access
